DailyStocks Stock Article Search

https://www.fool.com/investing/2020/03/25/3-reasons-pharma-stocks-are-a-buy-right-now.aspx?source=iedfolrf0000001 Mar 25, 2020 - The coronavirus outbreak has made shares of top drugmakers more attractive than they've been in a quite a while. 0

https://www.fool.com/investing/2020/03/26/3-big-pharma-stocks-plunging-the-most-during-the-c.aspx?source=iedfolrf0000001 Mar 26, 2020 - As a Magic 8-ball might say, "Signs point to yes." 0

https://www.fool.com/investing/2020/03/27/3-dirt-cheap-healthcare-stocks-to-buy-right-now.aspx?source=iedfolrf0000001 Mar 27, 2020 - Bargain prices and tremendous growth prospects make these stocks really attractive. 0

https://www.fool.com/investing/2020/03/30/4-reasons-drug-stocks-are-a-buy-right-now.aspx?source=iedfolrf0000001 Mar 30, 2020 - Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19. 0

https://www.fool.com/investing/2020/04/02/top-3-healthcare-stocks-to-buy-right-now.aspx?source=iedfolrf0000001 Apr 02, 2020 - With the coronavirus pandemic pushing stock prices to historic lows, there are plenty of promising companies to invest in today. 0

https://www.fool.com/investing/2020/04/06/former-celgene-drug-earns-a-key-approval-for-brist.aspx?source=iedfolrf0000001 Apr 06, 2020 - Reblozyl recently became the first treatment for adults with lower-risk myelodysplastic syndromes. 0

https://www.fool.com/investing/2020/04/16/3-great-stocks-that-are-still-ridiculously-cheap-r.aspx?source=iedfolrf0000001 Apr 16, 2020 - And two of the three offer nice dividends, too. 0

https://www.fool.com/investing/2020/04/26/3-bargain-stocks-you-can-buy-right-now.aspx?source=iedfolrf0000001 Apr 26, 2020 - These stocks won't be available at the current discounts for too long. 0

https://www.fool.com/investing/2020/03/26/3-industries-that-are-no-brainer-buys-right-now.aspx?source=iedfolrf0000001 Mar 26, 2020 - The coronavirus isn't going to be a headwind for any of these industries. 0

https://www.fool.com/investing/2020/03/26/bristol-myers-squibbs-multiple-sclerosis-drug-a-po.aspx?source=iedfolrf0000001 Mar 26, 2020 - But the big drugmaker will delay its commercial launch due to the COVID-19 pandemic. 0